Voices: Bikash Chatterjee
Industry’s adoption of lean principles has had a tangible impact on business performance across the life sciences. As pressure to drive down costs and improve productivity has escalated over the last decade we have seen lean applied as a foundation for programs ranging from facility design to product development. The last decade has been defined by change—whether the change is a result of consolidation, innovation or regulatory policies. It is unlikely the next decade will be any different. However, if we look at the construct of the current industry business models there are elements that will likely be integral to any future business strategy.Read More
More from this voice...
A Framework for Technology Transfer to Satisfy the Requirements of the New Process Validation Guidance: Part 2May 22, 2012In the life of any drug product, the technology transfer of a process is a complex matter, made more complicated by the new definition of the Process Validation (PV) guidance issued by FDA in January 2011.
- Feb 15, 2012Now that emerging pharma markets are tightening their grip on quality, are U.S. manufacturers losing theirs?
- Oct 5, 2011Revived interest in SPC only heightens the need for new data architecture models
- Jul 20, 2011The challenge all quality professionals face is answering the question, How much is enough?
- Feb 2, 2011What has emerged from Pharma's tough journey is a newfound appreciation for business performance.